Finanzen von DNA X Inc (SONM)SONMDNA X Inc

DNA X Inc (SONM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Smartphones, accounting for 50.0% of total sales, equivalent to $8.11M. Other significant revenue streams include Connected solutions and Feature Phones. Understanding this composition is critical for investors evaluating how SONM navigates market cycles within the Phones & Handheld Devices industry.

In the context of the broader market, SONM competes directly with industry leaders such as IVDA and UTSI. With a market capitalization of $4.58M, it holds a significant position in the sector. When comparing efficiency, SONM's gross margin of N/A stands against IVDA's 54.69% and UTSI's -13.59%. Such benchmarking helps identify whether DNA X Inc is trading at a premium or discount relative to its financial performance.

Sonim Technologies has struggled with revenue generation, reporting $0.00 in total revenue for multiple quarters. The net income has been consistently negative, with a loss of $4.75 million in Q3 2025 and a gross margin of only 11.20% in Q3 2025, indicating challenges in profitability. The company's current ratio is 0.76, which raises concerns about its ability to cover short-term liabilities.